World-renowned stem cell researcher introduces his studies at the World Economic Forum

DAVOS, Switzerland - Jan. 27, 2014 - PRLog -- Highly regarded stem cell-researcher and orthopedic surgeon, Brian Mehling, MD has just completed a successful series of speeches at the World Economic Forum Annual Meeting this past week in Davos-Klosters, Switzerland.

Dr. Mehling’s American based company Blue Horizon International and Blue Horizon Stem Cells released research studies and the results became the buzz of Davos. His lectures about the unique possibilities that lay in his research and the treatments were discussed with hundreds of attendees at the event.

"The response has been overwhelming both in formal meetings, as well as in informal talks,” said the surgeon. "Yesterday my Norwegian colleague met the Crown Prince of Norway and talked about stem cells. It is very motivating to hear that they are very positive to the stem cell research done by Blue Horizon Stem Cells. And, the Crown Prince told us that he was in the opinion that there is no doubt that the future of medicine is in continuous stem cell research."

As founder, Dr. Mehling has overseen a newly opened treatment and research facility in Bratislava, Slovakia. He has also managed the premiere of a clinic in China where over 2,600 stem cell treatment procedures on over 600 patients have been successfully performed. By strategically placing their new clinic in Slovakia the most innovative treatments within the stem cell field are now available for the global market.

Interviews with Dr Mehling and BHSC patients who attended the World Economic Forum can be arranged through the BHSC media offices at (212) 206-0902.

Blue Horizon International is a healthcare consulting company with a unique mission that combines treatment, research and philanthropic efforts. Across the globe quality care and services for medical treatments are provided along with resources needed to assist children and adults who are medically underserved. For more information please visit Blue Horizon International atwww.bluehorizoninternational.com

Blue Horizon Stem Cells is a division of Blue Horizon International that provides stem cell therapy and research to achieve health benefits. Uniquely positioned to take advantage of its clinical research, Blue Horizon Stem Cells has safely and efficiently performed over 2250 procedures, documenting each procedure while tracking the progress of patients throughout their treatment cycle. Blue Horizon International’s stem cell therapy program is associated with The Stem Cell Centre, Hongqiao Brain Hospital and Wuhan University School of Basic Medical Science in Wuhan, China and Medissimo Hospital in Bratislava, Slovakia. For more information visit www.bluehorizonstemcells.com